コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 varying concentrations to 11.5 degrees Plato wort.
2 ted system and its application to St. John's wort.
3 roduced during the alcoholic fermentation of wort.
4 rforin, the psychoactive agent in St. John's wort.
5 sed in the perioperative period by St John's wort.
6 Many HIV-infected persons use St. John's wort.
7 ntrations up to 50% lower comparing to sweet wort.
8 ereby counteracting pro-apoptotic effects of Wort.
9 this, embryos were cultured with wortmannin (Wort), a PI3K inhibitor, with or without IL-7 after part
15 inorganic supplementations: standard brewers wort, ammonia-nitrogen, inorganic phosphate, potassium,
16 he optimal conditions under which a range of wort and beer analytes can be extracted and quantified w
17 t relatively low concentrations of copper in wort and beer can adversely affect the stability of hop-
18 umerous studies dealing with the analysis of wort and beer flavour-related compounds by HS-SPME follo
20 ophan and arginine were the monitored AAs in wort and finished beer, which were extracted through cat
22 n p65 subunit in HT29 treated with St John's Wort and in PC3 treated with thyme might point to the NF
25 ra, garlic, ginkgo, ginseng, kava, St John's wort, and valerian are commonly used herbal medications
29 el microbes grow spontaneously and transform wort/beer composition, being Dekkera bruxellensis and Sa
31 ition and key aroma compounds of barley malt wort beverages produced from fermentation using six lact
32 wn to interact strongly with Cu(II) in sweet wort, binds to Cu(II) to form stable complexes in beer.
33 rmal decarboxylation of cinnamic acid during wort boiling or by enzymatic decarboxylation during ferm
37 bonitrile, or the herbal medicine, St John's wort, cholesterol precipitation was prevented by increas
40 PI3K) at reperfusion using LY or Wortmannin (Wort) during the first 15 minutes of reperfusion complet
41 herbal supplements (ginkgo biloba, St John's wort, echinacea, ginseng, garlic, saw palmetto, kava kav
42 signed to specific VOMs, as 3-methylbutanal (wort), ethyl alcohol and ethyl octanoate (fermentation,
44 andomly assigned to receive either St John's wort extract (n = 98; 900 mg/d for 4 weeks, increased to
45 derivatives in the kynurenine pathway during wort fermentation using a multi-response kinetic model a
46 and kynurenic acid formation were faster in wort fermented with S. cerevisiae than with S. pastorian
47 nts during alcoholic fermentation of brewers wort, fermented using three independent yeast strains, S
50 The importance of free fatty acids (FFAs) in wort has been known for a long time because of their inf
54 tonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhi
55 rpurea), ginseng (Panax ginseng), St John' s wort (Hypericum perforatum), and kava (Piper methysticum
56 y acids, S-adenosyl-L-methionine, St. John's wort [Hypericum perforatum]), exercise, and second-gener
58 f yeast propagation and distribution in beer worts in the course of various fermentation processes.
60 when these drugs are combined with St John's wort; induction of mania in depressed patients who mix a
66 s that long-term administration of St John's wort may result in diminished clinical effectiveness or
67 al trials have been conducted with St John's wort, most have significant flaws in design and do not e
70 dy, a commercial ale yeast was propagated in wort on a large scale (30 hL) for 24 h or 72 h and seede
71 cond+LY, P<0.01; 56.2+/-10.1% with Postcond+ Wort; P<0.01), suggesting that Postcond protects the hea
72 migrating monarchs and their use of swallow-wort (Pattalias palustre) in the spring as an important
73 d to a more traditional mash in terms of the wort quality produced (laboratory scale) from five unmal
76 glycerol) during the fermentation process in wort samples by amperometric enzymatic biosensors develo
79 XR is hyperforin, a constituent of St John's wort (SJW) extracts and potent inducer of human CYP3A4.
84 nteresting parameters of beta-glucan in beer wort, such as the molecular weight averages, fraction de
87 given the probe drugs along with 1 St John's wort tablet to establish postadministration CYP activity
88 curred with greater frequency with St John's wort than placebo (39/95 [41%] vs 25/100 [25%], respecti
89 ness was significantly higher with St John's wort than with placebo (P =.02), but the rates were very
90 nephrine reuptake inhibitors, and St. John's wort) that reported clinical outcomes were selected.
91 ermine and characterize beta-glucans in beer wort using size exclusion chromatography coupled with a
97 es an increase in the level of mycotoxins in wort was observed during mashing followed by a decrease
102 ing steps - aldehydes and furans dominate in wort, whereas the aliphatic esters and alcohols predomin
103 a profile of AAs (<LQ-99 ug mL(-1)) for each wort, which can be used as indicator of the quality of a